VVector Bio specializes in manufacturing Lentivirus vectors, adeno-associated virus (AAV), recombinant adenovirus vectors, enveloped virus-like particles (eVLPs), and recombinant proteins. They offer process and analytical development for viral vector manufacturing, with a focus on Lentivirus vectors and AAV from HEK-293 suspension cells. Additionally, they provide manufacturing services for AAV from the baculovirus-insect cell system. The company's goal is to make cell and gene therapy accessible to every patient by innovating and creating a more efficient and cost-effective manufacturing process. They offer biomanufacturing services to accelerate the development and commercialization of novel medicines.